Shaily Shah
Internal Medicine · Tampa, FLNPI 1205095478
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 168 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 16.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $874 and has fallen 97.5% since, to $22 in 2025.
Across 168 payments — averaging $17.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$479
- Amgen$220
- Boehringer Ingelheim$186
- Johnson & Johnson$183
- Pfizer$164
- AstraZeneca$162
- plus $1K from 27 others
What the payments were for
- Food & beverage$2,892100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 28 | $479 |
| Amgen | 16 | $220 |
| Boehringer Ingelheim | 9 | $186 |
| Johnson & Johnson | 11 | $183 |
| Pfizer | 12 | $164 |
| AstraZeneca | 12 | $162 |
| Sanofi-aventis U.S. LLC | 8 | $143 |
| AbbVie(2 entities) | 8 | $127 |
| Eisai Inc. | 5 | $106 |
| Lilly USA, LLC | 7 | $101 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $95 |
| Corcept Therapeutics | 5 | $94 |
| Novartis | 6 | $94 |
| Biohaven Pharmaceuticals, Inc. | 4 | $87 |
| Abbott | 5 | $84 |
| Carl Zeiss Meditec Cataract Technology Inc. | 1 | $76 |
| Astellas Pharma US Inc | 3 | $67 |
| Merck | 3 | $46 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $38 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $34 |
| Arbor Pharmaceuticals, Inc. | 2 | $34 |
| Optinose US, Inc. | 2 | $33 |
| Biotissue Holdings Inc. | 1 | $33 |
| GSK | 2 | $30 |
| Boston Scientific | 1 | $30 |
| Hikma Pharmaceuticals USA | 1 | $22 |
| Bausch & Lomb Americas Inc. | 1 | $22 |
| Amarin Pharma, Inc. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Vertiflex, Inc. | 1 | $18 |
| Medtronic | 1 | $17 |
| Bausch Health US, LLC | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
How this compares
$2,892 in reported general payments places this provider in the 85th percentile of 8,530 internal medicine providers in Florida.
Other internal medicine in Tampa
- Andrew KuykendallTampa$322K
- Jhanelle GrayTampa$229K
- Anitha ReddyTampa$224K
- Benjamin CreelanTampa$212K
- Anne HermannTampa$139K
- Mark LaflammeTampa$119K
- Shahla BariTampa$56K
- Haytham ElgammalMiami$2.2M
- Keith RubinFort Lauderdale$2M
- Michael SensionFort Lauderdale$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.